Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics (OTLK) Q1 2026 Earnings
OTLK
17
Feb
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.54
-0.38
-0.22
-0.06
Details
Expected EPS
-0.226667
Actual EPS
-0.22
Surprise EPS
0.01
Surprise Percent
+2.94%
Description
Outlook Therapeutics (OTLK) has reported earnings of -0.22 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login